.ALX Oncology's phase 2 stomach cancer cells response cost has actually weakened. After finding its ...
.One More of Ionis Pharmaceuticals' key midphase readouts has disappointed expectations, causing the...
.While Biogen's pharma peers are actually hunting for late-stage assets along with little threat, ch...
.Instil Bio has actually been a biotech searching for a pipeline after it scrapped its own lead reso...
.Biogen has actually restored civil rights to an early Alzheimer's illness course to Denali Therapeu...
.Accept to this week's Chutes & Ladders, our summary of considerable leadership hirings, firings ...
.Tip's effort to treat an unusual genetic ailment has actually struck an additional drawback. The bi...
.Vir Medical's second-quarter revenues document had not been except significant information. The com...
.Galapagos has stopped briefly enrollment in a trial of a BCMA-directed CAR-T tissue treatment, push...
.After more than thirty years, genetics treatment innovator James Wilson M.D., Ph.D., is actually le...